اكتشف أفضل عيادات وتكاليف العلاج علاج SIRT في إسرائيل 2026

SIRT therapy, or Y90 radioembolization, is a minimally invasive treatment for inoperable liver tumors. In Israel, interventional radiologists inject radioactive Yttrium-90 microspheres into the liver artery. These beads lodge in tumor vessels, delivering targeted beta radiation while preserving healthy surrounding tissue.

• Procedure approach: Radiologists use a catheter-based internal radiation method to treat vascular tumors.
• Technology standards: Israeli centers utilize SIR-Spheres approved by the Ministry of Health and FDA.
• Survival outcomes: Local clinical studies indicate life expectancy increases of 10 months or more.
• Typical cost: In Israel, SIRT therapy costs between $24,500 and $33,500.

Bookimed Expert Insight: Israeli oncology centers like Sourasky manage high patient volumes, seeing 40,000 cancer patients annually. This massive throughput allows specialists like Dr. Pelles Sharon to refine delivery protocols. High volumes often correlate with better outcomes in complex interventional radiology procedures.

Patient Consensus: Patients often refer to this treatment specifically as Y90 radioembolization. Many emphasize that this is internal radiation, which differs significantly from external beam therapies like SBRT.

SIRT treatment is safe and fully approved in Israel for treating inoperable liver tumors. The Israeli Ministry of Health, Joint Commission International (JCI), and FDA approve SIR-Spheres for clinical use. Leading oncology centers like Sourasky Medical Center (Ichilov) utilize this minimally invasive radioactive bead therapy safely.

• Regulatory approval: The Israeli Ministry of Health officially approves SIRT using Yttrium-90 microspheres.
• Accredited facilities: Clinics like Sourasky and Assuta maintain JCI accreditation for oncology safety.
• Targeted safety: Radioactive beads deliver localized radiation, minimizing damage to healthy liver tissue.
• Specialist expertise: Oncologists like Dr. Pelles Sharon provide SIRT within multidisciplinary liver cancer teams.

Bookimed Expert Insight: While SIRT protocol for liver cancer is established, patients must distinguish it from SIRT-6 protein research. Israeli scientists are leaders in SIRT-6 age-reversing studies, but these are currently pre-clinical. When booking, specify selective internal radiation therapy to ensure you are reaching clinical oncology departments instead of research labs.

Patient Consensus: Patients are often advised to double-check if their specific case qualifies for SIRT versus other approved options like CAR-T therapy. High satisfaction is reported when coordinating with hospital international departments to verify the availability of certified radioactive isotopes.

SIRT therapy in Israel is a minimally invasive procedure delivering radioactive Yttrium-90 microspheres directly to liver tumors. Performed by specialists like Dr. Pelles Sharon at Sourasky Medical Center, it targets cancer cells with high-dose radiation while sparing healthy tissue and typically requires one week of recovery.

• Procedure approach: surgeons inject radioactive beads via the bloodstream through the femoral artery.
• Treatment goal: therapy often shrinks tumors to make patients eligible for surgical removal later.
• Recovery timeline: patients must plan for at least 7 days of complete physical rest.
• Post-op sensations: common side effects include significant exhaustion and discomfort at the arterial access site.

Bookimed Expert Insight: Israeli oncology centers like Sourasky manage massive volumes, seeing 40,000 cancer patients annually. This high frequency means teams are exceptionally fast at identifying the exact vascular map needed for bead delivery. Their expertise often reduces the time patients spend under specialized imaging, which minimizes overall radiation exposure during the mapping phase.

Patient Consensus: Many find the fatigue after SIRT more intense than expected, often lasting several weeks. While liver pain can linger for months, it is generally manageable with standard medication and rest.

SIRT therapy is available at major Israeli oncology centers including Sourasky Medical Center, Sheba Medical Center, and Assuta Medical Center. These JCI-accredited facilities provide radioembolization for liver cancer using multidisciplinary teams of interventional radiologists and nuclear medicine specialists in Tel Aviv and Ramat Gan.

• Specialized clinic: Sourasky Medical Center treats 40,000 cancer patients yearly using advanced radiotherapy.
• Expert physician: Dr. Sharon Pelles at Sourasky focuses on SIRT for gastrointestinal oncology.
• Advanced alternative: Sheba Medical Center offers SIRT alongside NanoKnife and microwave liver ablation.
• High-tech infrastructure: Assuta Medical Center provides SIRT within Israel's largest private medical complex.

Bookimed Expert Insight: While many patients search for SIRT, Israeli specialists like Dr. Beni Boursi at Sheba Medical Center often evaluate if NanoKnife or microwave ablation might be more effective. Choosing a hospital that offers all three technologies ensures your treatment is selected based on clinical need rather than equipment availability.

Patient Consensus: Patients are often advised to request radioembolization by name when contacting clinics. General sentiment highlights that major institutions have high radiotherapy capacity, often performing other advanced treatments like CAR-T alongside SIRT.